Contrast-induced nephropathy in non-cardiac vascular procedures, a narrative review: Part 1

2021 ◽  
Vol 19 ◽  
Author(s):  
Juliette Raffort ◽  
Fabien Lareyre ◽  
Niki Katsiki ◽  
Dimitri P Mikhailidis

: Contrast-induced nephropathy (CIN) is an important complication of iodinated contrast medium (CM) administration, which is associated with both short- and long-term adverse outcomes (e.g., cardiorenal events, longer hospital stay, and mortality). CIN has been mainly studied in relation to cardiac procedures, but it can also occur following non-cardiac vascular interventions. This is Part 1 of a narrative review summarizing the available literature on CIN after non-cardiac vascular diagnostic or therapeutic procedures for aortic aneurysm and carotid stenosis. We discuss the definition, pathophysiology, incidence, risk factors, biomarkers, and consequences of CIN in these settings, as well as preventive strategies and alternatives to limit iodinated CM use. Physicians and vascular surgeons should be aware of CM-related adverse events and the potential strategies to avoid them. Clearly, more research in this important field is required.

2016 ◽  
Vol 2 (1) ◽  
pp. 52-58
Author(s):  
Andre Tjie Wijaya ◽  
Budiawan Atmadja

The increase of application of iodinated contrast medium in diagnostic practice, combined with the increase of renal insufciency patients and elderly resulted in increasing incidency of contrast-induced nephropathy (CIN). The use of iodinated contrast medium need a careful assessment between risk and beneft, especially in patients with history of renal disease and elderly.  Assessment of renal function is based on glomerular fltration rate, not serum creatinine. Avoidance of iodinated contrast medium is the frst step to prevent the development of CIN. Consideration of alternative imaging is important. But, if iodinated contrast medium is needed, volume expansion intravenous before and after administration is the next acknowledged prevention step.


2021 ◽  
Vol 19 ◽  
Author(s):  
Juliette Raffort ◽  
Fabien Lareyre ◽  
Niki Katsiki ◽  
Dimitri P Mikhailidis

: This is Part 2 of a narrative review summarizing the literature on CIN after non-cardiac vascular diagnostic or therapeutic procedures, focusing on peripheral artery disease (PAD) and renal artery stenosis (RAS). Part 1 discussed CIN in relation to aortic aneurysms and carotid stenosis. We comment on the incidence, biomarkers, risk factors, and consequences of CIN in patients with PAD or RAS, as well as on strategies to prevent CIN. Future perspectives in the field of CIN in relation to non-cardiac vascular procedures are also considered.


2021 ◽  
pp. 405-413
Author(s):  
Cecelia Allison ◽  
Vaibhav Sharma ◽  
Jason Park ◽  
Clemens M. Schirmer ◽  
Ramin Zand

Contrast-induced encephalopathy (CIE) is a rare complication that arises from exposure to iodinated contrast medium and can result in a range of symptoms, including cortical blindness, aphasia, focal neurological deficits, and altered mental status. We present 4 individual cases of CIE who presented with stroke-mimic symptoms following surgery with localized iodixanol or ioversol injection. We outline a clinical timeline of all patients, showing that CIE follows a general pattern of delayed onset, worsening symptomology, and ultimately full recovery. All patients received IV hydration, corticosteroids, or both as part of their treatment protocol.


Angiology ◽  
2021 ◽  
pp. 000331972110125
Author(s):  
Atalay Demiray ◽  
Baris Afsar ◽  
Adrian Covic ◽  
Masanari Kuwabara ◽  
Charles J. Ferro ◽  
...  

Increased serum uric acid (SUA) levels have been associated with various pathologic processes such as increased oxidative stress, inflammation, and endothelial dysfunction. Thus, it is not surprising that increased SUA is associated with various adverse outcomes including cardiovascular (CV) diseases. Recent epidemiological evidence suggests that increased SUA may be related to acute myocardial infarction (AMI). Accumulating data also showed that elevated UA has pathophysiological role in the development of AMI. However, there are also studies showing that SUA is not related to the risk of AMI. In this narrative review, we summarized the recent literature data regarding SUA and AMI after providing some background information for the association between UA and coronary artery disease. Future studies will show whether decreasing SUA levels is beneficial for outcomes related to AMI and the optimum SUA levels for best outcomes in CV diseases.


Radiology ◽  
2009 ◽  
Vol 253 (3) ◽  
pp. 870-878 ◽  
Author(s):  
Douglas B. Macha ◽  
Rendon C. Nelson ◽  
Laurens E. Howle ◽  
John W. Hollingsworth ◽  
Sebastian T. Schindera

1974 ◽  
Vol 291 (1) ◽  
pp. 24-25 ◽  
Author(s):  
Manfred Blum ◽  
Uzi Weinberg ◽  
Louis Shenkman ◽  
Charles S. Hollander

2015 ◽  
Vol 26 (9) ◽  
pp. 3310-3318 ◽  
Author(s):  
Shu Min Tao ◽  
Julian L. Wichmann ◽  
U. Joseph Schoepf ◽  
Stephen R. Fuller ◽  
Guang Ming Lu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document